$114 Million is the total value of Canaan Partners XI LLC's 5 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TYRA BIOSCIENCES INC | $60,725,576 | -19.1% | 4,409,991 | 0.0% | 53.26% | +0.1% | ||
| DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $30,571,453 | +0.5% | 2,491,561 | -2.2% | 26.81% | +24.4% |
| AEVA | AEVA TECHNOLOGIES INC | $14,141,176 | -38.8% | 18,485,197 | 0.0% | 12.40% | -24.2% | |
| RALLYBIO CORP | $6,941,229 | -40.5% | 2,059,712 | 0.0% | 6.09% | -26.3% | ||
| New | MONEYLION INCcl a | $1,635,573 | – | 75,581 | +100.0% | 1.44% | – | |
| VECT | Exit | VECTIVBIO HLDG AG | $0 | – | 0 | +100.0% | 0.00% | – |
| Exit | MONEYLION INCcl a | $0 | – | -75,581 | -100.0% | -0.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DAY ONE BIOPHARMACEUTICALS I | 8 | Q3 2023 | 61.6% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 53.3% |
| AEVA TECHNOLOGIES INC | 8 | Q3 2023 | 36.0% |
| RALLYBIO CORP | 8 | Q3 2023 | 14.1% |
| VECTIVBIO HLDG AG | 7 | Q2 2023 | 0.3% |
| BIRD GLOBAL INC | 5 | Q4 2022 | 0.1% |
| MONEYLION INC | 1 | Q3 2023 | 1.4% |
| MONEYLION INC | 1 | Q2 2023 | 0.6% |
View Canaan Partners XI LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-05 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2023-10-11 |
| 13F-HR | 2023-07-13 |
| 13F-HR | 2023-04-06 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-10-31 |
| 4 | 2022-09-22 |
| 4 | 2022-09-20 |
| 4 | 2022-09-15 |
View Canaan Partners XI LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.